Jim Heath is the Elizabeth Gilloon Professor and Professor of Chemistry at Caltech, and Professor of Molecular and Medical Pharmacology at UCLA. He has directed the National Cancer Institute funded NSB Cancer Center since 2005. He received his Ph.D. in 1988 from Rice University where he was the principle graduate student involved in the discovery of C60 and the fullerenes. He was a Miller Fellow at UC Berkeley before joining the research staff at IBM Watson Labs in 1991. He took a faculty position at UCLA in 1994, and moved to Caltech in 2003. He has received several awards, including the Irving Weinstein Award from the American Association of Cancer Researchers, and the Sackler Prize in the Physical Sciences. He has founded or cofounded several companies, including Integrated Diagnostics, Indi Molecular, Sofie Biosciences, Isoplexis, and NanoSys. He was named by Forbes in 2009 as one of the top 7 innovators in the world. Heath is a member of the Stand Up 2 Cancer Immunotherapy Dream Team, and the Parker Institute for Cancer Immunotherapy.
Google Scholar Citations: https://scholar.google.com/citations?hl=en&user=W_ZpqUwAAAAJ&view_op=list_works
Presentation Title: New Technologies for Personalizing Cancer Immunotherapies